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1. Background
Uterine adenosarcomas are composed of benign epithelium asso-
ciated with a malignant stromal component. These tumors generally
have low malignant potential resulting in a more favorable prognosis
than other sarcomas (Kobayashi et al., 2013). Genetic associations or
predispositions are largely unknown (Kobayashi et al., 2013).
The DICER1 gene product is an endoribonuclease responsible for
processing microRNA (miRNA) (Chen et al., 2015). The majority of
human genes are regulated by miRNAs. Given the key role of miRNA in
gene expression, DICER1 is thought to play a large role in tumorigenesis
and is oftentimes referred to as a tumor suppressor gene (Chen et al.,
2015).
Germline mutations in the DICER1 gene have been associated with
various lesions, speciﬁcally pleuropulmonary blastoma, cystic nephro-
ma, multinodular goiter (MNG), Wilms tumor, ovarian Sertoli-Leydig
cell tumor, and cervical embryonal rhabdomyosarcoma (Doros et al.,
1993). Chen et al. recently demonstrated an association between
somatic DICER1 mutations and endometrial carcinomas and carcino-
sarcomas (Chen et al., 2015). Similarly, Conlon et al. found that 2.4% of
The Cancer Genome Atlas endometrial carcinoma genomes harbored
DICER1 hotspot mutations (Conlon et al., 2016). Zigheilboim et al.
demonstrated a correlation between decreased DICER1 expression and
reduced disease-free survival in patients with endometrioid endome-
trial tumors (Zighelboim et al., 2011). Despite these associations
between DICER1 and endometrial carcinomas, the association of
DICER1 with uterine adenosarcomas has only recently been suggested
(Piscuoglio et al., 2016).
We report on a 27-year-old woman who presented with a missed
abortion. Pathologic examination of the products of conception re-
vealed adenosarcoma and scant products of conception. Germline
genetic testing revealed a DICER1 mutation.
2. Case
A 27-year-old woman, gravida 2, para 1 presented to her obste-
trician for abnormal uterine bleeding. Her urine beta-human chorionic
gonadotropin (HCG) was negative, but serum HCG was 17 IU/L.
Ultrasound demonstrated a small gestational sac in the right cornu
with a 6-week sized embryo with absent fetal heart motion. The patient
underwent hysteroscopy, dilation, and curettage (D & C). The endome-
trial curettage specimen demonstrated fragments of endometrial tissue
admixed with tissue that was highly atypical in appearance. Histologic
sections showed abnormal endometrial tissue in polypoid leaf-like
conﬁgurations and some glands with dilated, serrated proﬁles
(Fig. 1A). The stroma was predominantly ﬁbrotic, but in other areas
it was cellular. The more cellular areas were concentrated around the
serrated glands in the manner of a “cambium” layer (Fig. 1B). Stromal
mitoses were identiﬁed in the periglandular cuﬀs (Fig. 1C). Clustered
thick-walled blood vessels were seen elsewhere in the tissue fragments.
Portions of tissue were largely infarcted. Within these infarcted areas
were highly atypical stromal cells with pleomorphic nuclei and mitotic
ﬁgures (Fig. 1D). These portions resembled a high-grade sarcoma.
Another component represented normal background endometrium.
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Immunostains were performed. Estrogen receptor was present in the
endometrial-like areas, but absent in the high-grade sarcoma. The
sarcomatoid areas were negative for p63, PLAP, and inhibin which
would be positive in various forms of trophoblastic disease.
Cytokeratins AE1/3 demonstrated a dot-like pattern of positivity in
the sarcomatoid areas, which is characteristic of Mullerian adenosarco-
ma. Ki-67 showed a proliferation index approaching 80% in the most
proliferative areas of the sarcoma and highlighted endometrial stromal
cells within the cambium layer surrounding endometrial glands. An
immunostain for beta-hCG highlighted one focus of tissue that on H & E
appeared consistent with highly degenerated chorionic villi and
trophoblast, conﬁrming pregnancy. Myogenin and desmin stains were
negative, excluding rhabdomyosarcoma. The ﬁnal interpretation was
Mullerian adenosarcoma with sarcomatous overgrowth. Repeat curet-
tage of the endometrium demonstrated similar ﬁndings. An outside
consultation was obtained, supporting the interpretation.
Computed tomography (CT) of the chest, abdomen, and pelvis was
normal without evidence of metastatic disease. The patient underwent
surgical staging with a DaVinci robot-assisted total laparoscopic
hysterectomy, bilateral salpingectomy, and sentinel lymph node dis-
section with ovarian preservation. She was referred to reproductive
endocrinology prior to surgery for fertility preservation. On laparo-
scopy, the patient was noted to have a normal uterus, bilateral tubes,
and ovaries with no evidence of metastatic disease. On bivalve of the
uterus there was no obvious tumor. Pathology demonstrated no
evidence of malignancy in the uterus, bilateral fallopian tubes, or
sentinel lymph nodes. Given Stage I disease, the decision was made for
no adjuvant therapy and follow-up with serial CT scans.
Of note, the patient had a history of an endometrial polyp in 2013, a
lung bleb at age 16 years old, and a self-reported thyroid nodule in
2006 for which she underwent hemithyroidectomy. The polyp from
2013 was obtained for review. This showed an endocervical polyp that
was predominantly necrotic. One of the rare areas of viable tissue
showed stromal cells whose nuclei were enlarged. A few nuclei were
hyperchromatic with coarse chromatin, and there was one apparent
mitotic ﬁgure. Upon initial review these changes were attributed to
vascular injury; however, the presence of atypical stromal cells in the
2013 material is noteworthy in retrospect. Also of note, at age 16 the
patient presented with 6-month history of cough. Chest CT demon-
strated a 20.3 × 10.4 cm, loculated emphysematous bleb. After resec-
tion the patient had no residual symptoms. The pathology was reported
in 2005 as a cyst with focal ﬁbrosis. However, upon reexamination of
the specimen with knowledge of the patient's germline DICER1 muta-
tion, pathology was felt to be consistent with a type I regressed (Ir)
pleuropulmonary blastoma (PPB; Fig. 2). This was conﬁrmed by expert
consultation.
The patient was referred to a genetic counselor and underwent
germline testing through a 42-gene Common Hereditary Cancers Panel
(Invitae Genetics). Sequencing showed a heterozygous germline
DICER1mutation (c.3007C > T, p.Arg1003*). By creating a premature
stop codon, this nonsense mutation is predicted to result in an absent or
truncated protein with disrupted function. According to the COSMIC
database, the mutation is present near the middle of the 1923-amino
acid protein, in the PAZ domain, and is N-terminal to the two
ribonuclease domains that are required for function. The mutation is
C-terminal to the helicase and dimerization domains, suggesting a
possible dominant-negative function of the mutant protein if one is
produced. This variant is not listed as a polymorphism in the NHLBI
Exome Variant Server or in the UCSC Genome Browser. However, this
speciﬁc mutation has been reported previously in an individual with
pleuropulmonary blastoma and the variant is therefore classiﬁed as
pathogenic. We did not test tumor tissue to identify a possible somatic
second-hit mutation.
Fig. 1. Histologic appearance of Mullerian adenosarcoma in endometrial curettings. (A) Abnormal endometrial tissue in a polypoid conﬁguration, containing dilated and serrated glands.
H & E, original magniﬁcation 100×. (B) Condensation of stroma around glands. H & E, 40×. (C) Abnormal stromal mitotic ﬁgures at center of panel, including one tripolar mitosis. H & E,
400×. (D) Vascular areas with bizarre stromal nuclei. H & E, 200×.
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3. Discussion
We report a case of adenosarcoma in a patient with a germline
DICER1 mutation who initially presented for a missed abortion.
Interestingly, the patient underwent polypectomy years prior, had a
childhood pulmonary emphysematous bleb consistent with type Ir
pleuropulmonary blastoma, and a thyroid nodule hypothetically repre-
senting multinodular goiter.
Adenosarcomas comprise ~8% of all uterine sarcomas (Kobayashi
et al., 2013). The median age of presentation is 58 years, and the typical
presentation is irregular bleeding secondary to a large polypoid mass in
the endometrial cavity (Kobayashi et al., 2013). While this patient was
younger than the median age of presentation, 13% of patients present
prior to 30 years old and up to 38% prior to 50 years old (Clement and
Scully, 1990). Hysteroscopy demonstrated a polypoid structure in the
right cornual region characteristic of adenosarcoma's usual mass
appearance. Her adenosarcoma was typical in that it was early-stage,
but there was notable sarcomatous overgrowth which could represent a
more aggressive variant (Kobayashi et al., 2013; Clement and Scully,
1990). The relationship between the adenosarcoma and our patient's
pregnancy is diﬃcult to ascertain. It is possible the missed abortion led
to the diagnosis of the sarcoma. Additionally, the presence of the
adenosarcoma may have contributed to pregnancy failure.
Adenosarcoma is often a diﬃcult pathologic diagnosis and is
frequently misinterpreted (Clement and Scully, 1990). In one series,
5% of patients with adenosarcoma were misdiagnosed with benign
polyps on two or more occasions prior to their ﬁnal diagnosis.
Particularly in young women, recurrent endocervical and/or endome-
trial polyps are unusual and should raise a red ﬂag (Clement and Scully,
1990). Of note, 22% of adenosarcomas contain heterologous sarcoma-
tous stromal elements and samples often contain extensive ﬁbrosis
which can confer a misleading benign appearance (Clement and Scully,
1990).
Germline DICER1 mutations have never been described in endome-
trial adenosarcomas until this case. However, Piscuoglio et al. char-
acterized somatic genetic mutations in 20 cases of uterine adenosarco-
mas and found DICER1 to be one of three genes recurrently mutated in
the mesenchymal component of the uterine adenosarcomas occurring in
10.5% of the cases (Piscuoglio et al., 2016). Of note, one of the tumors
with a hotspot DICER1 mutation had sarcomatous overgrowth similar
to our patient. Interestingly, the pathology of uterine adenosarcoma
shares similarities with PPB and Wilms tumor which are both com-
monly associated with germline DICER1 mutations. All three tumors
demonstrate sarcomatous cells associated with an epithelial component
(Chen et al., 2015; Priest et al., 2006). Therefore, it is not surprising
that this tumor is associated with a similar genetic predisposition.
Further research is necessary, but perhaps uterine adenosarcoma is the
uterine dysontogenetic analogue to these tumors.
The patient's lung lesion was reinterpreted by a subspecialty
pediatric pathologist as a type Ir PPB. Whereas the lung lesion was
resected in 2005, the features of type I PPBs were not well described
until 2006 (Seki et al., 2014), before which they were often diagnosed
as benign blebs. Our patient has not experienced any sequelae from her
lesion, which is not uncommon.
Lastly, while no data was available regarding the patient's thyroid
nodule, the history might be considered suspicious for multinodular
goiter (MNG) which has also been associated with germline DICER1
mutations (Doros et al., 1993).
This case demonstrates a patient with uterine adenosarcoma and a
germline DICER1 mutation. Our observations provide insight into the
genetic aberrations associated with adenosarcoma, and expand the
spectrum of DICER1-related disease. Further research is necessary to
determine the exact role, if any, that DICER1 plays in the pathogenesis
of adenosarcoma.
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Fig. 2. Histologic appearance of patient's type Ir PPB. (A) Thin-walled multilocular subpleural cysts. H & E, original magniﬁcation 20×. (B) Variably cellular cyst walls without obvious
“cambium” layer. H & E, 40×. (C) Benign respiratory-type epithelium with focal cilia. H & E, 600×.
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